Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients

The prognosis of advanced esophageal cancer patients is poor. Trimodality therapy of surgical resection plus neoadjuvant chemoradiotherapy (CRT) has been developed to improve survival through locoregional control, leading to prevention of micrometastasis. We investigated whether or not neoadjuvant C...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology reports 2012-08, Vol.28 (2), p.446-452
Hauptverfasser:	FUJIWARA, YOSHINORI, YOSHIKAWA, REIGETSU, KAMIKONYA, NORIHIKO, NAKAYAMA, TSUYOSHI, KITANI, KOTARO, TSUJIE, MASANORI, YUKAWA, MASAO, INOUE, MASATOSHI, YAMAMURA, TAKEHIRA
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer therapies Carcinoma, Squamous Cell - pathology Carcinoma, Squamous Cell - therapy Chemoradiotherapy Chemotherapy Classification Disease-Free Survival Endoscopy Esophageal cancer Esophageal Neoplasms - pathology Esophageal Neoplasms - therapy Esophageal Squamous Cell Carcinoma esophagectomy Esophagectomy - methods Esophagus Female Gastrointestinal surgery Humans Lymphatic system Male Medical imaging Medical prognosis Metastasis Middle Aged Multivariate analysis Neoadjuvant Therapy Neoplasm Staging Ostomy Patients Prognosis Radiation therapy Randomized Controlled Trials as Topic Response rates Retrospective Studies Squamous cell carcinoma Studies Surgery survival Survival Analysis Treatment Outcome Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!